Printed from https://ideas.repec.org/s/plo/pmed008.html
Content
May 2005, Volume 2, Issue 5
- 1-1 Why We Need to Rethink the Diseases of Affluence
by Thomas E Novotny - 1-1 The Global Prevalence of Schizophrenia
by Dinesh Bhugra - 1-1 Taking More Than a Fair Share? The Migration of Health Professionals from Poor to Rich Countries
by Delanyo Dovlo - 1-1 Fundamental Limits to the Precision of Early Warning Systems for Epidemics of Infectious Diseases
by John M Drake - 1-1 Authors' Reply: Don't Let the Hypothesis Slip
by Ben A Lopman & Geoff P Garnett & Simon Gregson & Simon Gregson & Peter R Mason - 1-1 HIV Epidemiology in Africa: Weak Variables and Tendentiousness Generate Wobbly Conclusions
by Stuart Brody & John J Potterat - 1-1 A Systematic Review of the Prevalence of Schizophrenia
by Sukanta Saha & David Chant & Joy Welham & John McGrath
April 2005, Volume 2, Issue 4
- 1-1 The Problem with Academic Medicine: Engineering Our Way into and out of the Mess
by Jonathan Rees - 1-1 telederm.org: Freely Available Online Consultations in Dermatology
by H Peter Soyer & Rainer Hofmann-Wellenhof & Cesare Massone & Gerald Gabler & Huiting Dong & Fezal Ozdemir & Giuseppe Argenziano - 1-1 Nonstationary Influence of El Niño on the Synchronous Dengue Epidemics in Thailand
by Bernard Cazelles & Mario Chavez & Anthony J McMichael & Simon Hales - 1-1 Integrating Equity into Health Information Systems: A Human Rights Approach to Health and Information
by Lexi Bambas
February 2005, Volume 2, Issue 3
- 1-1 Designing an Equitable Strategy for Allocating Antiretroviral Treatments
by Alexander M Capron & Andreas Reis
March 2005, Volume 2, Issue 3
- 1-1 How Does PLoS Medicine Manage Competing Interests?
by The PLoS Medicine Editors - 1-1 Hookworm: “The Great Infection of Mankind”
by Peter J Hotez & Jeff Bethony & Maria Elena Bottazzi & Simon Brooker & Paulo Buss - 1-1 Statement of Principles for Health Care Journalists
by Gary Schwitzer - 1-1 Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis
by Jeremy G Wheeler & Kelsey D M Juzwishin & Gudny Eiriksdottir & Vilmundur Gudnason & John Danesh
February 2005, Volume 2, Issue 2
- 1-1 The Courage to Change the Rules: A Proposal for an Essential Health R&D Treaty
by Nicoletta Dentico & Nathan Ford - 1-1 Why Bigger Is Not Yet Better: The Problems with Huge Datasets
by The PLoS Medicine Editors - 1-1 Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries
by David P Wilson & Sally M Blower
January 2005, Volume 2, Issue 1
- 1-1 Trade and Health: Is the Health Community Ready for Action?
by Kelley Lee & Meri Koivusalo - 1-1 Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology?
by Ross McKinney & David Korn - 1-1 Deadly Alliances: Death, Disease, and the Global Politics of Public Health
by Matthew Gandy
December 2004, Volume 1, Issue 3
- 1-1 The Commercialisation of Medical and Scientific Reporting
by Timothy Caulfield - 1-1 Is It Ethical to Use Enhancement Technologies to Make Us Better than Well?
by Arthur Caplan & Carl Elliott - 1-1 Finding Cures for Tropical Diseases: Is Open Source an Answer?
by Stephen M Maurer & Arti Rai & Andrej Sali
November 2004, Volume 1, Issue 2
- 1-1 Enzyme Replacement in Gaucher Disease
by Ernest Beutler - 1-1 A National Health Insurance Program for the United States
by Don R McCanne
October 2004, Volume 1, Issue 1
- 1-1 New Drugs for Neglected Diseases: From Pipeline to Patients
by Bernard Pécoul - 1-1 The Global Health Watch
by Mike Rowson & David McCoy & Amit Sen Gupta & Armando de Negri Filho
September 2004, Volume 1, Issue 1
- 1-1 The Birth of Reproductive Health: A Difficult Delivery
by Shereen El Feki